Education Clearinghouse

The CLIC Education Clearinghouse is a centralized space where the CTSA community can find and share a variety of education and workforce development resources for a broad range of audiences, from the general public to Principal Investigators. Users can select and filter through a number of different areas: learning domains, tags (keywords), target learners, and more. Each entry presents a detailed profile of the resource so that users can efficiently choose a resource that’s right for them. These detailed profiles provide links (and access instructions, if needed) to the resources on the hub or external institution that is hosting the content.


Competencies
Top Tags
Target Learners
Advanced filters
  • CLIC

    Looking for new strategies for your KL2 or TL1 program? Are you worried about a lack of diversity and inclusion within your institution? How are you ensuring the diversity of the clinical science workforce? Not sure where to start? From Insights to Action is a collection of actionable questions inspired by hubs’ stories of ongoing progress and success in the Careers in Clinical & Translational

  • The toolkit comprises a set of power point slide sets (modules) intended to serve as a resource for persons delivering presentations aiming to heighten and facilitate older adult inclusion in clinical and translational research.
  • Medical College Of Wisconsin

    I invite you to listen to our latest CTSI Discovery Radio Episode #102: Artificial Intelligence and Ethics of AI in Healthcare. Artificial Intelligence is impacting and changing many industries, and that includes healthcare. But, discoveries in Artificial Intelligence come with ethical issues and challenges that must be addressed. Explore Artificial Intelligence and the Ethics of AI in Healthcare

  • Georgetown University
    Howard University
    MedStar Washington Hospital Center
    George Washington University

    Session recordings are now available from the DC CTSA Consortium's 2022 DC CTSA Spring Regulatory Update & Hot Topics in Clinical and Translational Research. DAY 1 - LASTING IMPACTS OF THE COVID-19 PANDEMIC (APRIL 28, 2022) - Keynote Address - Transcriptome profiling of human blood as a platform for diagnostic biomarker development: Measure broadly, listen carefully - Panel 1: Long-term COVID-19

  • University of Virginia

    Welcome to the Team Science module! Transdisciplinary collaboration has become more prevalent in this era as many disciplines of study have begun encouraging collaborative efforts that unite researchers from diverse scientific backgrounds to address complex questions and societal problems with a multidisciplinary approach.

  • What is the CTSA Compendium of D&I Catalogs? A curated list of resource catalogs relevant to the conduct of Dissemination & Implementation (D&I) science, developed by the Clinical & Translational Science Awards (CTSA) Program’s “Advancing Dissemination and Implementation Sciences in CTSAs” working group. The resource catalogs gathered here include frameworks/theories/models, methods/measures
  • This resource kit was featured during the 5th International Symposium on Urea Cycle Disorders, Satellite to the 14th International Congress on Inborn Errors of Metabolism, titled “Mapping Progress: Current Concepts and New Insights in Urea Cycle Disorders,” which was hosted virtually by the Urea Cycle Disorders Consortium September 22-24, 2021.

  • This presentation was featured during the 5th International Symposium on Urea Cycle Disorders, Satellite to the 14th International Congress on Inborn Errors of Metabolism, titled “Mapping Progress: Current Concepts and New Insights in Urea Cycle Disorders,” which was hosted virtually by the Urea Cycle Disorders Consortium September 22-24, 2021. Topic: Day 3 Discussion Panel (09/24/2021) Speakers

  • This presentation was featured during the 5th International Symposium on Urea Cycle Disorders, Satellite to the 14th International Congress on Inborn Errors of Metabolism, titled “Mapping Progress: Current Concepts and New Insights in Urea Cycle Disorders,” which was hosted virtually by the Urea Cycle Disorders Consortium September 22-24, 2021. Topic: The Dawn of Genomic Medicine in the Treatment

  • This presentation was featured during the 5th International Symposium on Urea Cycle Disorders, Satellite to the 14th International Congress on Inborn Errors of Metabolism, titled “Mapping Progress: Current Concepts and New Insights in Urea Cycle Disorders,” which was hosted virtually by the Urea Cycle Disorders Consortium September 22-24, 2021. Topic: N-Carbamylglutamate In the Treatment of

  • This presentation was featured during the 5th International Symposium on Urea Cycle Disorders, Satellite to the 14th International Congress on Inborn Errors of Metabolism, titled “Mapping Progress: Current Concepts and New Insights in Urea Cycle Disorders,” which was hosted virtually by the Urea Cycle Disorders Consortium September 22-24, 2021. Topic: Transplant Decision Making in Urea Cycle

  • This presentation was featured during the 5th International Symposium on Urea Cycle Disorders, Satellite to the 14th International Congress on Inborn Errors of Metabolism, titled “Mapping Progress: Current Concepts and New Insights in Urea Cycle Disorders,” which was hosted virtually by the Urea Cycle Disorders Consortium September 22-24, 2021. Topic: Dietary Interventions in UCDs Speaker: Debra

  • This presentation was featured during the 5th International Symposium on Urea Cycle Disorders, Satellite to the 14th International Congress on Inborn Errors of Metabolism, titled “Mapping Progress: Current Concepts and New Insights in Urea Cycle Disorders,” which was hosted virtually by the Urea Cycle Disorders Consortium September 22-24, 2021. Topic: Newborn Screening for Proximal UCD - Are We

  • This presentation was featured during the 5th International Symposium on Urea Cycle Disorders, Satellite to the 14th International Congress on Inborn Errors of Metabolism, titled “Mapping Progress: Current Concepts and New Insights in Urea Cycle Disorders,” which was hosted virtually by the Urea Cycle Disorders Consortium September 22-24, 2021. Topic: Day 2 Discussion Panel (09/23/2021) Speakers

  • This presentation was featured during the 5th International Symposium on Urea Cycle Disorders, Satellite to the 14th International Congress on Inborn Errors of Metabolism, titled “Mapping Progress: Current Concepts and New Insights in Urea Cycle Disorders,” which was hosted virtually by the Urea Cycle Disorders Consortium September 22-24, 2021. Topic: Biomarkers for Liver Disease in Urea Cycle

  • This presentation was featured during the 5th International Symposium on Urea Cycle Disorders, Satellite to the 14th International Congress on Inborn Errors of Metabolism, titled “Mapping Progress: Current Concepts and New Insights in Urea Cycle Disorders,” which was hosted virtually by the Urea Cycle Disorders Consortium September 22-24, 2021. Topic: Chronic Liver Involvement in Urea Cycle

  • This presentation was featured during the 5th International Symposium on Urea Cycle Disorders, Satellite to the 14th International Congress on Inborn Errors of Metabolism, titled “Mapping Progress: Current Concepts and New Insights in Urea Cycle Disorders,” which was hosted virtually by the Urea Cycle Disorders Consortium September 22-24, 2021. Topic: FDA: Scientific and Regulatory Insights into

  • This presentation was featured during the 5th International Symposium on Urea Cycle Disorders, Satellite to the 14th International Congress on Inborn Errors of Metabolism, titled “Mapping Progress: Current Concepts and New Insights in Urea Cycle Disorders,” which was hosted virtually by the Urea Cycle Disorders Consortium September 22-24, 2021. Topic: EEG and Neuroimaging Studies: What Have We

  • This presentation was featured during the 5th International Symposium on Urea Cycle Disorders, Satellite to the 14th International Congress on Inborn Errors of Metabolism, titled “Mapping Progress: Current Concepts and New Insights in Urea Cycle Disorders,” which was hosted virtually by the Urea Cycle Disorders Consortium September 22-24, 2021. Topic: How Can Animal Models Inform Us About the

  • This presentation was featured during the 5th International Symposium on Urea Cycle Disorders, Satellite to the 14th International Congress on Inborn Errors of Metabolism, titled “Mapping Progress: Current Concepts and New Insights in Urea Cycle Disorders,” which was hosted virtually by the Urea Cycle Disorders Consortium September 22-24, 2021. Topic: Neurocognitive Outcomes Related to Treatment

  • University Of Utah

    Dr. Adam Ware discusses his research on pediatric cardiology and the impact CTSI has had on it.

  • University of Arkansas for Medical Sciences

    This video covers why it is important to include older adults in research, with tips for including this often-overlooked population.

  • University of Iowa

    This is the first of five sessions Session 1: Overview of systematic literature reviews (SLR) and meta-analysis and key considerations when performing a SLR Session 2: Designing data abstraction forms and quality and bias assessment tools Session 3: Heterogeneity, pooling data – fixed vs. random effects, and publication bias Session 4: MOOSE and PRISMA criteria Session 5: Meta-Analysis of

  • University of Iowa

    This is the third of five sessions Session 1: Overview of systematic literature reviews (SLR) and meta-analysis and key considerations when performing a SLR Session 2: Designing data abstraction forms and quality and bias assessment tools Session 3: Heterogeneity, pooling data – fixed vs. random effects, and publication bias Session 4: MOOSE and PRISMA criteria Session 5: Meta-Analysis of

  • University of Iowa

    This is the second of 5 sessions Session 1: Overview of systematic literature reviews (SLR) and meta-analysis and key considerations when performing a SLR Session 2: Designing data abstraction forms and quality and bias assessment tools Session 3: Heterogeneity, pooling data – fixed vs. random effects, and publication bias Session 4: MOOSE and PRISMA criteria Session 5: Meta-Analysis of

  • Columbia University Health Sciences

    To learn of the creative springs of today's science, Dr. Rita Charon interviews leading scientists, for the US National Institutes of Health (NIH) Narratives of Discovery project. She draws on their thoughts, imagination and analytical minds to illuminate the interconnections among the modes of knowing, seeing, and telling in the medical sciences. The fifth article in the series is now published

  • The Older Veteran Engagement Team –An Example of the Value of Engaging Older Adults in Research is intended to complement the Community-Engaged Research (CEnR) with Diverse Older Adult module. This module provides a case example of the application of the 5Ts framework for inclusion of older adults in research and an equally illustrative case example of the application of the 5Ms framework in

  • University of Iowa

    This is the fourth in a series of five sessions. Session 1: Overview of systematic literature reviews (SLR) and meta-analysis and key considerations when performing a SLR Session 2: Designing data abstraction forms and quality and bias assessment tools Session 3: Heterogeneity, pooling data – fixed vs. random effects, and publication bias Session 4: MOOSE and PRISMA criteria Session 5: Meta

  • Osteogenesis Imperfecta Foundation

    On June 24, 2021 Tracy Hart, CEO of the OI Foundation, and Dr. Deborah Krakow, OIF Medical Advisory Council (MAC) member, discussed women's health and pregnancy research. This conversation is part of a series highlighting the work of the Brittle Bone Disorders Consortium (BBDC), a multi-center program that focuses on understanding and providing better treatment options for all types of

  • Osteogenesis Imperfecta Foundation

    On Wishbone Day, May 6, 2021, Cameron Penn, President of the OIF Board of Directors, interviewed Dr. Brendan Lee, Principal Investigator for the Brittle Bone Disease Consortium (BBDC). Their discussion covered the history of the BBDC, current OI research, and answered audience questions. This conversation is part of a series highlighting the work of the Brittle Bone Disorders Consortium (BBDC), a